Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1043 results for "first pharma"

GlaxoSmithKline Pharma Q1 dips 5% to Rs 93 crore
Money Control

GlaxoSmithKline Pharma Q1 net dips 5% to Rs 93 cr

GlaxoSmithKline Pharmaceuticals today reported a 5.09 per cent decline in its net profit at Rs 93.28 crore for the first quarter ended June 30, hit by supply constraints. The company had posted a net profit of Rs 98.29 crore for the same period of ... Hindu Business Line, 11 hours ago
GlaxoSmithKline Pharma Q1 dips 5% to Rs 93 cr Business Standard, 11 hours ago

246 images for first pharma

Wall Street Pit, 4 days ago
Bloomberg, 1 week ago
Business Standard, 4 days ago
Business Standard, 4 days ago, 1 week ago
Business Insider India, 1 week ago
Bite, 1 week ago
Business Standard, 1 week ago
Securities Technology Monitor, 1 week ago
Business Standard, 1 week ago

Dr. Reddy's first quarternet profit up 14%

Pharma major Dr. Reddy's Laboratories has posted a net profit of Rs.625.7 crore for the quarter ended June 30, a 14 per cent increase over the Rs.550.4 crore registered in the year ago period. The revenue at Rs.3,757.8 crore was seven per cent ...
 The Hindu1 day ago Dr Reddy's Labs Q1 revenue, profit up  Pharma Letter9 hours ago Dr Reddy’s Q4 net profit up at Rs518.9 crore  The Financial Chronicle2 months ago

GlaxoSmithKline Pharma net drops 5 percent in Q1

2014 , drops , first , Friday , June , percent New Delhi, July 31 (IANS) GlaxoSmithKline Pharmaceuticals posted net profit of Rs.93.28 crore for the first quarter of 2015-16, a drop of 5.09 percent to Rs.98.29 crore in the corresponding quarter ...
 Can India News8 hours ago

Glenmark Pharma Q1 net up 3%

Drugmaker Glenmark Pharmaceuticals clocked a 3 per cent increase in the consolidated net profit for the first three months of the financial year ended June 30, 2015. The consolidated net profit stands at ₹190 crore, as compared to ₹184 crore ...
 Hindu Business Line1 day ago Shasun Pharma Q1 PAT at Rs. 3.8 cr  FirstWord Pharma1 day ago Alembic Pharma Q1 net up 8% to Rs 70 crore  Times of India7 hours ago Alembic Pharma Q1 Net Up 8% to about Rs 70 Cr  NDTV Profit9 hours ago

First pharma IPO in 5 years: Syngene's debut offer subscribed 32 times

MUMBAI: The Rs 550-crore initial public offer of Syngene, a research arm of Biocon, was subscribed 32 times on the final day of the offer on Wednesday led by heavy demand from high networth investors and institutions. This is the second-highest ...
 Economic Times1 day ago

Reliance Sec downgrades Torrent Pharma to 'Hold'

Reliance Securities has downgraded Torrent Pharmaceuticals to 'Hold' after the company declared its first quarter results. The stock broker fixed price target at Rs 1,400. Commenting on the results, Edelweiss Research said, ''Torrent reported an ...
 MyIris2 days ago

Lupin buys Gavis to gain first US manufacturing site

Indian drug manufacturer Lupin is expanding to the US by purchasing Gavis pharma for $880 million, in a major boost to its manufacturing and production capabilities. Acquiring Gavis gives Lupin access to 66 generic drugs, which the New Jersey firm ...
 Pharmafile3 days ago Lupin acquires US generics firm GAVIS for $880 mn  Rediff.com1 week ago Lupin takes over Gavis for $880m  The Financial Chronicle1 week ago Lupin to acquire US-based Gavis for $880 mn  Deccan Herald1 week ago

Capital First, HDFC Bank, Glenmark Pharma and Bajaj Auto preferred picks: Hemang Jani, Sharekhan

We think that this is a good time to actually go in the market and start accumulating good stocks, says Hemang Jani.
 Economic Times4 weeks ago
India Infoline

Intas to launch its first biosimilar in US in 9-12 mths

Intas Pharmaceuticals, a vertically integrated pharma company, today said it expects to launch its first biosimilar in the US within 9-12 months. Intas is the only domestic firm with two biosimilars filed for registration in the US and it looks to ...
 Business Standard1 month ago Intas Pharma plans to launch its first biosimilar in US: Reports  India Infoline1 month ago

Guwahati could emerge as pharma hub for South East Asia: Ananth Kumar

To be spread across 89 acres of land, the first phase of construction, amounting to Rs 160 cr, has started from today and that the total project cost would be to the tune of Rs 550 cr BS Reporter | Guwahati May 31, 2015 Last Updated at 20:18 IST Guwahati ...
 Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less